Skip to main content

Table 1 Summary of mutations included in the curated whole genome drug resistance library

From: Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences

Drug

Loci

No. variable sites

SNPs

Indels

INH

katG

241

286

25

 

katG promoter

3

3

0

 

inhA

12

15

0

 

inhA promoter

9

11

0

 

ahpC

8

8

0

 

ahpC promoter

13

14

0

 

kasA

8

11

0

RMP

rpoB

89

135

19

 

rpoC

8

8

0

EMB

embB

123

153

1

 

embA

5

5

0

 

embA promoter

3

3

0

 

embC

25

26

0

 

embR

22

24

0

STR

rrs

21

25

0

 

rpsL

14

19

0

PZA

pncA

215

269

64

 

pncA promoter

4

6

0

 

rpsA

3

4

0

 

panD

9

11

1

ETH

ethA

33

29

5

 

ethR

3

4

0

 

inhA promoter

3

3

0

 

inhA

3

3

0

FLQs

gyrA

15

22

0

 

gyrB

22

29

0

AMK

rrs

8

9

0

CAP

rrs

3

4

0

 

tlyA

26

18

10

KAN

rrs

3

4

0

 

eis promoter

9

10

0

PAS

thyA

23

17

5

 

folC

16

19

0

 

ribB

1

1

0

LZD

rrl

2

2

0

 

rplC

1

1

0

BDQ CFZ

Rv0678

7

5

2

  1. AMK, amikacin; BDQ, bedaquiline; CAP, capreomycin; CFZ, clofazimine; EMB, ethabutol; ETH, ethionamide; FLQs, fluoroquinolones; INH, isoniazid; KAN, kanamycin; LZD, linezolid; PAS, para-aminosalycylic acid; PZ, pyrazinamide; RMP, rifampicin; STR, streptomycin.